Cellular reprogramming by the conjoint action of ERα, FOXA1, and GATA3 to a ligand-inducible growth state

Area of Science:

• Molecular Biology
• Genomics
• Cancer Research

Background:

• The estrogen receptor alpha (ERα) pathway is a critical driver of breast cell growth.
• Introducing ERα into ERα-negative cells paradoxically leads to growth inhibition, a phenomenon not fully understood.

Purpose of the Study:

• To investigate the binding profiles of ERα, FOXA1, and GATA3 in breast cancer cells.
• To elucidate the formation and function of a potential enhanceosome complex involving these factors.
• To understand the role of this complex in regulating ERα-driven gene expression and cell growth.

Main Methods:

• Mapping of ERα, FOXA1, and GATA3 binding profiles in MCF-7 cells.
• Analysis of enhanceosome-occupied sites for enhancer characteristics (p300 recruitment, RNA Pol II occupancy, chromatin accessibility).
• Transfection experiments in ERα-negative cell lines (MDA-MB-231, BT-549) to assess restoration of estrogen-responsive growth.

Main Results:

• ERα, FOXA1, and GATA3 form a functional enhanceosome in MCF-7 cells.
• This enhanceosome regulates core ERα-driven genes and modulates transcriptional networks.
• Enhanceosome-occupied sites exhibit optimal enhancer features, including high p300 and RNA Pol II occupancy and open chromatin.
• Co-transfection of all three factors reprogrammed ERα-negative cells to exhibit estrogen-responsive growth.

Conclusions:

• The enhanceosome complex of ERα, FOXA1, and GATA3 is essential for the full spectrum of ERα-associated effects in breast cancer.
• All components of this enhanceosome are necessary to restore estrogen-responsive growth in ERα-negative cells.
• This finding highlights the cooperative role of these TFs in ERα pathway function and breast cancer progression.